Psychedelics are a hot topic, and a drug called ibogaine is receiving attention after a recent shoutout from U.S. President Donald Trump. University of Calgary psychedelics researcher Leah Mayo explains what ibogaine is, and why limited high-quality research has her hesitant to recommend it.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.